Delivery Order SPE2DB22D2006-SPE2DB25FW2BP

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,992.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of June 6, 2025. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order worth $1,565.13 for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, on June 5, 2025 with an ultimate completion date of June 6, 2025. The contract is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award, valued at $2,302.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period extending to July 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract is a Firm Fixed Price Delivery Order valued at $1,838.56 with a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,792.93, is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.19 firm fixed-price contract is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period ending on December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product. The contract has an award value of $1,867.32 and a completion date of April 2, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides medical products and supplies to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $7,407.35 and is a delivery order with a firm fixed-price pricing type. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM medical supplies. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,423.97 and provides the DLA with Firm Fixed Price delivery orders for AIRSUPRA 90-80 MCG INHALER 10.7GM medical supplies. The contract has an ultimate completion date of November 7, 2024. This award is associated with AmerisourceBergen's existing...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,565.49, is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product. It is a firm fixed-price delivery order contract with an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW2BP
    Delivery Order

This federal contract award is a delivery order with a firm fixed price of $7,114.96 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period through June 30, 2025. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical and medical products to support military healthcare programs. The contract award is not designated as a set-aside.

Generated 9/26/25, 9:50 AM